Trial site
University of Pennsylvania Perelman School of Medicine
- 13running trials
- 8closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Depression4 trials
- Bladder cancer3 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Familial hypercholesterolaemia2 trials
- Gastric and oesophageal cancer2 trials
- Prostate cancer2 trials
- COPD1 trial
- Crohn's disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Head and neck cancer1 trial
- High blood pressure1 trial
- and 9 more
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Recruiting5 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- CG Oncology, Inc.2 trials
- Northwestern University2 trials
- University of Pennsylvania2 trials
- Incyte Corporation1 trial
- and 10 more
Running trials
Not yet recruiting
Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3
Recruiting
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Familial hypercholesterolaemia2 recruiting
- Colorectal cancer1 recruiting
- COPD1 recruiting
- Depression1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Obesity1 recruiting
- Prostate cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sarcoidosis1 recruiting
Closed trials
Completed
Completed
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Completed
Terminated
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026